MODERN APPROACHES TO THE PREVENTION AND TREATMENT OF PREECLAMPSIA DURING PREGNANCY
Keywords:
Preeclampsia, pregnancy, hypertension, maternal healthAbstract
Preeclampsia is a hypertensive disorder of pregnancy with severe complications for both maternal and fetal health. Despite being a major cause of maternal and neonatal morbidity, effective strategies for early detection, prevention, and treatment remain critical. This article reviews the latest approaches to managing preeclampsia, focusing on evidence-based prevention strategies such as low-dose aspirin, lifestyle modifications, and nutritional interventions. Moreover, it highlights recent advancements in diagnostic biomarkers and emerging therapies like targeted gene therapies and anti-sFlt-1 treatments. The analysis emphasizes multidisciplinary approaches to improve maternal and neonatal outcomes worldwide.
References
American College of Obstetricians and
Gynecologists. (2020). Low-Dose Aspirin in the
Prevention of Preeclampsia. ACOG Guidelines.
Redman, C. P., & Sargent, I. L. (2005). Latest
Advances in the Pathophysiology of
Preeclampsia.
Roberts, J. M., & Hubel, C. A. (2009).
Mechanisms of Endothelial Dysfunction in
Preeclampsia. Obstetrics & Gynecology.
Magee, L. A., & Mistry, H. D. (2021). Advances
in Early Detection of Preeclampsia Using
Biomarkers. The Lancet.
Ghosh, R., & Sharma, M. (2022). Innovative
Therapies for Preeclampsia: Gene Therapy and
Anti-sFlt-1 Strategies. The New England
Journal of Medicine.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
